Results 191 to 200 of about 8,013,600 (393)

Deep learning to automatically evaluate HER2 gene amplification status from fluorescence in situ hybridization images. [PDF]

open access: yesSci Rep, 2023
Xue T   +13 more
europepmc   +1 more source

Human tumor cell lines with EGF receptor gene amplification in the absence of aberrant sized mRNAs [PDF]

open access: green, 1985
C. Richter King   +5 more
openalex   +1 more source

Analysis of comprehensive genomic profiling of solid tumors with a novel assay for broad analysis in clinical diagnostics

open access: yesMolecular Oncology, EarlyView.
In molecular cancer diagnostics, comprehensive genomic profiling (CGP) is going to replace the small NGS panels since it provides all clinically relevant somatic variants as well as genomic biomarkers with clinical value. Here, we compared two CGP assays and demonstrate that the choice for diagnostic implementation will depend on the specific ...
Guy Froyen   +17 more
wiley   +1 more source

SARS-CoV-2 Nucleocapsid Protein Mutations Found in Switzerland Disrupt N-Gene Amplification in Commonly Used Multiplex RT-PCR Assay. [PDF]

open access: yesPathogens, 2023
Hilti D   +7 more
europepmc   +1 more source

Amplification and modification of dihydrofolate reductase in Escherichia coli. Nucleotide sequence of fol genes from mutationally altered plasmids.

open access: hybrid, 1982
Andrew R. Smith   +5 more
openalex   +1 more source

Response to neoadjuvant chemotherapy in early breast cancers is associated with epithelial–mesenchymal transition and tumor‐infiltrating lymphocytes

open access: yesMolecular Oncology, EarlyView.
Epithelial–mesenchymal transition (EMT) and tumor‐infiltrating lymphocytes (TILs) are associated with early breast cancer response to neoadjuvant chemotherapy (NAC). This study evaluated EMT and TIL shifts, with immunofluorescence and RNA sequencing, at diagnosis and in residual tumors as potential biomarkers associated with treatment response.
Françoise Derouane   +16 more
wiley   +1 more source

MET gene amplification is a mechanism of resistance to entrectinib in ROS1+ NSCLC. [PDF]

open access: yesThorac Cancer, 2022
Tyler LC   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy